I-TRAF is a novel TRAF-interacting protein that regulates TRAF-mediated signal transduction - PubMed (original) (raw)

I-TRAF is a novel TRAF-interacting protein that regulates TRAF-mediated signal transduction

M Rothe et al. Proc Natl Acad Sci U S A. 1996.

Abstract

Tumor necrosis factor (TNF) receptor-associated factor (TRAF) proteins associate with and transduce signals from TNF receptor 2, CD40, and presumably other members of the TNF receptor superfamily. TRAF2 is required for CD40- and TNF-mediated activation of the transcription factor NF-kappa B. Here we describe the isolation and characterization of a novel TRAF-interacting protein, I-TRAF, that binds to the conserved TRAF-C domain of the three known TRAFs. Overexpression of I-TRAF inhibits TRAF2-mediated NF-kappa B activation signaled by CD40 and both TNF receptors. Thus, I-TRAF appears as a natural regulator of TRAF function that may act by maintaining TRAFs in a latent state.

PubMed Disclaimer

Similar articles

• TTRAP, a novel protein that associates with CD40, tumor necrosis factor (TNF) receptor-75 and TNF receptor-associated factors (TRAFs), and that inhibits nuclear factor-kappa B activation.
  Pype S, Declercq W, Ibrahimi A, Michiels C, Van Rietschoten JG, Dewulf N, de Boer M, Vandenabeele P, Huylebroeck D, Remacle JE. Pype S, et al. J Biol Chem. 2000 Jun 16;275(24):18586-93. doi: 10.1074/jbc.M000531200. J Biol Chem. 2000. PMID: 10764746
• TRAF2-mediated activation of NF-kappa B by TNF receptor 2 and CD40.
  Rothe M, Sarma V, Dixit VM, Goeddel DV. Rothe M, et al. Science. 1995 Sep 8;269(5229):1424-7. doi: 10.1126/science.7544915. Science. 1995. PMID: 7544915
• Anatomy of TRAF2. Distinct domains for nuclear factor-kappaB activation and association with tumor necrosis factor signaling proteins.
  Takeuchi M, Rothe M, Goeddel DV. Takeuchi M, et al. J Biol Chem. 1996 Aug 16;271(33):19935-42. doi: 10.1074/jbc.271.33.19935. J Biol Chem. 1996. PMID: 8702708
• Tumor necrosis factor receptor-associated factors (TRAFs).
  Bradley JR, Pober JS. Bradley JR, et al. Oncogene. 2001 Oct 1;20(44):6482-91. doi: 10.1038/sj.onc.1204788. Oncogene. 2001. PMID: 11607847 Review.
• Tumor necrosis factor receptor-associated factor (TRAF) 2 and its role in TNF signaling.
  Wajant H, Scheurich P. Wajant H, et al. Int J Biochem Cell Biol. 2001 Jan;33(1):19-32. doi: 10.1016/s1357-2725(00)00064-9. Int J Biochem Cell Biol. 2001. PMID: 11167129 Review.

Cited by

• Heat shock protein HSPA13 promotes hepatocellular carcinoma progression by stabilizing TANK.
  Cen X, Lu Y, Lu J, Luo C, Zhan P, Cheng Y, Yang F, Xie C, Yin Z, Wang F. Cen X, et al. Cell Death Discov. 2023 Dec 8;9(1):443. doi: 10.1038/s41420-023-01735-0. Cell Death Discov. 2023. PMID: 38062023 Free PMC article.
• TANK shapes an immunosuppressive microenvironment and predicts prognosis and therapeutic response in glioma.
  Li S, Guo Y, Hu H, Gao N, Yan X, Zhou Q, Liu H. Li S, et al. Front Immunol. 2023 May 5;14:1138203. doi: 10.3389/fimmu.2023.1138203. eCollection 2023. Front Immunol. 2023. PMID: 37215097 Free PMC article.
• PLK1 protects intestinal barrier function during sepsis by targeting mitochondrial dynamics through TANK-NF-κB signalling.
  Cao YY, Zhang Y, Gerile W, Guo Y, Wu LN, Wu LL, Song K, Lu WH, Yu JB. Cao YY, et al. Mol Med. 2022 Dec 29;28(1):163. doi: 10.1186/s10020-022-00597-z. Mol Med. 2022. PMID: 36581806 Free PMC article.
• TNF Receptor Associated Factor 2 (TRAF2) Signaling in Cancer.
  Siegmund D, Wagner J, Wajant H. Siegmund D, et al. Cancers (Basel). 2022 Aug 22;14(16):4055. doi: 10.3390/cancers14164055. Cancers (Basel). 2022. PMID: 36011046 Free PMC article. Review.
• TANK prevents IFN-dependent fatal diffuse alveolar hemorrhage by suppressing DNA-cGAS aggregation.
  Wakabayashi A, Yoshinaga M, Takeuchi O. Wakabayashi A, et al. Life Sci Alliance. 2021 Nov 24;5(2):e202101067. doi: 10.26508/lsa.202101067. Print 2022 Feb. Life Sci Alliance. 2021. PMID: 34819357 Free PMC article.

References

1. 1. Gene. 1988 Jul 15;67(1):31-40 - PubMed
2. 1. J Biol Chem. 1994 Mar 11;269(10):7785-91 - PubMed
3. 1. J Biol Chem. 1994 Dec 2;269(48):30069-72 - PubMed
4. 1. Nature. 1989 Jul 20;340(6230):245-6 - PubMed
5. 1. Cell. 1995 May 19;81(4):495-504 - PubMed

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Atypon
  • Europe PubMed Central
  • PubMed Central

• Other Literature Sources

  • The Lens - Patent Citations

• Molecular Biology Databases

  • BioCyc
  • Gene Ontology
  • GlyGen glycoinformatics resource
  • Mouse Genome Informatics (MGI)

• Research Materials

  • NCI CPTC Antibody Characterization Program